Cargando…
Novel insights into the interplay between m6A modification and programmed cell death in cancer
N6-methyladenosine (m6A) methylation, the most prevalent and abundant RNA modification in eukaryotes, has recently become a hot research topic. Several studies have indicated that m6A modification is dysregulated during the progression of multiple diseases, especially in cancer development. Programm...
Autores principales: | Chen, Jinhao, Ye, Mujie, Bai, Jianan, Hu, Chunhua, Lu, Feiyu, Gu, Danyang, Yu, Ping, Tang, Qiyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092764/ https://www.ncbi.nlm.nih.gov/pubmed/37063421 http://dx.doi.org/10.7150/ijbs.81000 |
Ejemplares similares
-
Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer
por: Ye, Mujie, et al.
Publicado: (2023) -
ALKBH5 enhances lipid metabolism reprogramming by increasing stability of FABP5 to promote pancreatic neuroendocrine neoplasms progression in an m6A-IGF2BP2-dependent manner
por: Chen, Jinhao, et al.
Publicado: (2023) -
FABP5 regulates lipid metabolism to facilitate pancreatic neuroendocrine neoplasms progression via FASN mediated Wnt/β‐catenin pathway
por: Lu, Feiyu, et al.
Publicado: (2023) -
Orlistat Induces Ferroptosis in Pancreatic Neuroendocrine Tumors by Inactivating the MAPK Pathway
por: Ye, Mujie, et al.
Publicado: (2023) -
FAM201A encodes small protein NBASP to inhibit neuroblastoma progression via inactivating MAPK pathway mediated by FABP5
por: Ye, Mujie, et al.
Publicado: (2023)